Bisphosphonates in calcific aortic stenosis: Association with slower progression in mild disease - A pilot retrospective study

Cardiology

Volumn 117, Issue 3, 2011, Pages 184-189

  Sterbakova, Gabriela ^a   Vyskocil, Vaclav ^a   Linhartova, Katerina ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Aortic stenosis; Bisphosphonates; Osteoporosis; Valve calcification

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID;

AGED; AORTA STENOSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; ALENDRONATE; AORTIC VALVE STENOSIS; BONE DENSITY CONSERVATION AGENTS; CALCINOSIS; COMORBIDITY; DIPHOSPHONATES; DISEASE PROGRESSION; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PILOT PROJECTS; RETROSPECTIVE STUDIES;

EID: 78149428225     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321418     Document Type: Article

References (22)

1. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM: Clinical factors associated with calcific aortic disease. J Am Coll Cardiol 1997; 29: 630-634.
2. Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Goncalves F, Rajamannan NM: Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007; 49: 554-561.
3. Cowell SJ, Newby, DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA; Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators: A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005; 352: 2389-2397.
4. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke- Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R; SEAS Investigators: Intensive lipid lowering with simavastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359: 1343-1356.
5. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J; ASTRONOMER Investigators: Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010; 121: 306-314.
6. Aksoy Y, Yagmur C, Tekin GO, Yagmur J, Topal E, Kekilli E, Turhan H, Kosar F, Yetkin E: Aortic valve calcification: association with bone mineral density and cardiovascular risk factors. Coron Artery Dis 2005; 16: 379-383.
7. Linhartova K, Veselka J, Sterbakova G, Racek J, Topolcan O, Cerbak R: Parathyroid hormone and vitamin D levels are independently associated with calcific aortic stenosis. Circ J 2008; 2: 245-250.
8. Price PA, Faus SA, Williamson MK: Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 2001; 21: 817-824.
9. Price PA, Roublick AM, Williamson MK: Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006; 70: 1577-1583.
10. Hashiba H, Aizawa S, Tamura K, Kogo H: Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects. Ther Apher Dial 2006; 10: 59-64.
11. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M; American Society of Echocardiography; European Association of Echocardiography: Echocardiographic assessment of valve stenosis: EAE/ASE Recommendations for Clinical Practice. J Am Soc Echocardiogr 2009; 22: 2-23.
12. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ; American Society of Echocardiography: Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777-802.
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography: Recommendations for chamber quantification: a report from the American Society of Echocardiographýs Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
14. Skolnick AH, Osranek M, Formica P, Kronzon I: Osteoporosis treatment and progression of aortic stenosis. Am J Cardiol 2009; 104: 122-124.
15. Bonura F: Prevention, screening, and management of osteoporosis. Postgrad Med 2009; 121: 5-17.
16. Russell RG: Bisphosphonates: mode of action and pharmacology. Pediatrics 2007; 119 (suppl 2):150-162.
17. Qunibi WY, Nolan CA, Ayus JC: Cardiovascular calcification in patients with end-stage renal disease: a century old phenomenon. Kidney Int Suppl 2002; 82: 73-80.
18. Idris AI, Rojas J, Greig IR, Van't Hof RJ, Ralston SH: Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int 2008; 82: 191-201.
19. Persy V, De Broe M, Ketteler M: Bisphosphonates prevent experimental vascular calcification: treat the bone to cure the vessels? Kidney Int 2006; 70: 1357-1358.
20. Zittermann A, Schleithoff SS, Koerfer R: Vitamin D and vascular calcification. Curr Opin Lipidol 2007; 1: 41-46.
21. Yilmaz MB, Guray U, Guray Y Cihan G, Caldir V, Cay S, Kisacik HL, Korkmaz S: Lipid profile of patients with aortic stenosis might be predictive of rate of progression. Am Heart J 2004; 147: 915-918.
22. Antonini-Canterin F, Hîru M, Popescu BA, Leiballi E, Piazza R, Pavan D, Ginghinã C, Nicolosi GL: Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis. Am J Cardiol 2008; 102: 738-742.